JPWO2022186311A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022186311A5
JPWO2022186311A5 JP2023503935A JP2023503935A JPWO2022186311A5 JP WO2022186311 A5 JPWO2022186311 A5 JP WO2022186311A5 JP 2023503935 A JP2023503935 A JP 2023503935A JP 2023503935 A JP2023503935 A JP 2023503935A JP WO2022186311 A5 JPWO2022186311 A5 JP WO2022186311A5
Authority
JP
Japan
Prior art keywords
formula
acid
compound
minutes
atomic group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023503935A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022186311A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/009003 external-priority patent/WO2022186311A1/ja
Publication of JPWO2022186311A1 publication Critical patent/JPWO2022186311A1/ja
Publication of JPWO2022186311A5 publication Critical patent/JPWO2022186311A5/ja
Pending legal-status Critical Current

Links

JP2023503935A 2021-03-04 2022-03-02 Pending JPWO2022186311A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021034026 2021-03-04
JP2021146833 2021-09-09
PCT/JP2022/009003 WO2022186311A1 (ja) 2021-03-04 2022-03-02 化合物及び放射性標識化合物

Publications (2)

Publication Number Publication Date
JPWO2022186311A1 JPWO2022186311A1 (cg-RX-API-DMAC7.html) 2022-09-09
JPWO2022186311A5 true JPWO2022186311A5 (cg-RX-API-DMAC7.html) 2025-02-21

Family

ID=83155351

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023503935A Pending JPWO2022186311A1 (cg-RX-API-DMAC7.html) 2021-03-04 2022-03-02

Country Status (8)

Country Link
US (1) US20240174622A1 (cg-RX-API-DMAC7.html)
EP (1) EP4303213A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2022186311A1 (cg-RX-API-DMAC7.html)
KR (1) KR20230154183A (cg-RX-API-DMAC7.html)
AU (1) AU2022228911A1 (cg-RX-API-DMAC7.html)
CA (1) CA3210294A1 (cg-RX-API-DMAC7.html)
TW (1) TW202302542A (cg-RX-API-DMAC7.html)
WO (1) WO2022186311A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4196175A4 (en) * 2020-08-14 2025-07-30 Clarity Pharmaceuticals Ltd RADIOPHARMACEUTICAL COMPOUNDS, THEIR USES AND PROCESSES FOR THEIR PRODUCTION
CN116285684B (zh) * 2023-05-15 2023-08-08 四川绚度眼视光科技有限公司 一种多功能超亲水涂层及其制备方法与应用
CN116870176B (zh) * 2023-08-03 2025-08-12 浙江大学 PSMA靶向的PSMA-PARPi偶联物及制备方法和应用
WO2025220711A1 (ja) * 2024-04-17 2025-10-23 日本メジフィジックス株式会社 化合物、放射性標識化合物及びその製造方法、並びに放射性医薬組成物
WO2026014283A1 (ja) * 2024-07-09 2026-01-15 日本メジフィジックス株式会社 化合物、放射性標識化合物およびその製造方法、並びに放射性医薬組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060228364A1 (en) 1999-12-24 2006-10-12 Genentech, Inc. Serum albumin binding peptides for tumor targeting
GB0412181D0 (en) 2004-06-01 2004-06-30 Celltech R&D Ltd Biological products
CA2760839C (en) 2009-05-01 2019-02-12 The Trustees Of The University Of Pennsylvania Modified compstatin with peptide backbone and c-terminal modifications
CN108699108B (zh) 2016-03-01 2022-04-08 国立大学法人千叶大学 放射性标记药物
CN109982998A (zh) * 2016-11-23 2019-07-05 癌靶技术有限责任公司 白蛋白结合psma抑制剂
KR102724812B1 (ko) * 2017-04-05 2024-11-01 코넬 유니버시티 영상화 및 항종양 치료요법에 유용한 조정 가능한 약동학을 갖는 삼작용성 작제물
CA3060143A1 (en) * 2017-05-24 2018-11-29 Itm Isotopen Technologien Munchen Ag Novel psma-binding agents and uses thereof
CA3086454A1 (en) 2017-09-26 2019-04-04 National University Corporation Chiba University Radioactive drug
AU2018352731B2 (en) 2017-10-22 2023-10-05 Provincial Health Services Authority Novel radiometal-binding compounds for diagnosis or treatment of prostate specific membrane antigen-expressing cancer
KR102156385B1 (ko) * 2018-03-30 2020-09-15 (주)퓨쳐켐 전립선암 진단 및 치료를 위한 psma-표적 방사성의약품
US12202908B2 (en) 2018-05-17 2025-01-21 Astellas Pharma Inc. Complex having anti-human MUC1 antibody Fab fragment, peptide linker and/or ligand
MX2021004146A (es) 2018-10-10 2021-06-08 Astellas Pharma Inc Composicion farmaceutica que contiene complejo de fragmento fab de anticuerpo antihumano con sitio marcado.
KR20210116437A (ko) * 2018-11-20 2021-09-27 코넬 유니버시티 방사성핵종의 마크로사이클릭 복합체 및 암의 방사선 요법에서의 이의 용도
CA3118223A1 (en) * 2018-12-18 2020-06-25 Provincial Health Services Authority Dual mode 18f-labelled theranostic compounds and uses thereof
MX2021008230A (es) 2019-01-07 2021-08-11 Astellas Pharma Inc Conjugado que comprende ligando y fragmento fab de anticuerpo ceacam5.
MX2021013055A (es) * 2019-04-26 2021-12-10 Five Eleven Pharma Inc Inhibidores de antigenos de membrana especificos de prostata (psma) como agentes diagnosticos y terapeuticos con radionuclidos.
TWI908773B (zh) * 2020-03-04 2025-12-21 日商日本醫事物理股份有限公司 化合物及放射性標誌化合物

Similar Documents

Publication Publication Date Title
AU2019204121B2 (en) Compositions, methods, and systems for the synthesis and use of imaging agents
AU2008203856B8 (en) Stilbene derivatives and their use for binding and imaging amyloid plaques
JP5290954B2 (ja) スチリルピリジン誘導体及びアミロイド斑を結合させ画像化するためのその使用
AU2018279007A1 (en) Compositions, methods, and systems for the synthesis and use of imaging agents
AU2002323417A1 (en) Stilbene derivatives and their use for binding and imaging amyloid plaques
US11420910B2 (en) Methods for low temperature fluorine-18 radiolabeling of biomolecules
EP4303213A1 (en) Compound and radioactive labeling compound
AU2017307325B2 (en) Diagnosis, treatment and prevention of neurotensin receptor-related conditions
Procházková et al. Lanthanide (III) complexes of monophosphinate/monophosphonate DOTA-analogues: effects of the substituents on the formation rate and radiolabelling yield
AU2004210208B2 (en) Diagnostic imaging agents with MMP inhibitory activity
JPS5925397A (ja) 心筋イメ−ジ剤および方法
EP1553985A2 (en) Biphenyls and fluorenes as imaging agents in alzheimer's disease
JPH06298779A (ja) ヘテロ環イミノビスメチレンビスホスホン酸誘導体
JPWO1998027100A1 (ja) 放射性遷移金属窒化物ヘテロ錯体
Gano et al. Radiolanthanide complexes with tetraazamacrocycles bearing methylphosphonate pendant arms as bone seeking agents
Southcott et al. Bis (amido) bis (oxinate) diamine Ligands for theranostic radiometals
US8940273B2 (en) Tricarbonyl complexes with tridentate chelators for myocardium imaging
CN101182333A (zh) 一种99mTc标记的2-甲氧基苯基哌嗪类配合物及其制备方法和应用
Choi et al. Synthesis and Physical Evaluation of^ 9^ 9^ mTc (CO)~ 3-labeled Cysteine-arylpiperazines for a Neuroreceptor (5-HT~ 1~ A) Imaging
CN116940557A (zh) 化合物及放射性标记化合物
HK1211571B (en) Pyridazin-3(2h)-one derivatives as imaging agents for detecting myocardial perfusion